Neostigmine
Formulations: - Parenteral > General injections > unspecified: 0.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate); 2.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate) Oral > Solid > tablet: 15 mg (neostigmine bromide) Indications: - Myasthenia gravis - Anticholinesterase reversible Source: EML workbook import
MOQ: 1
Price on request
